{"entity":{"type":"insider","cik":"0001588862","url":"/insider/0001588862","json_url":"/insider/0001588862.json","name":"McWherter Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":15,"first":"2015-05-19","last":"2025-01-23","span_basis":"filed_date"},"name_variants":[{"name":"McWherter Charles","source":"filing","n_filings":15,"first_seen":"2015-05-19","last_seen":"2025-01-23"}],"transactions":[{"id":4130266,"accession":"0000950170-25-008461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-008461","line_url":"/filing/0000950170-25-008461#line-2","is_derivative":false,"issuer_cik":"0001588862","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001588862","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.71,"price_display":"6.71","price_state":"stated","total_value":67100.0,"total_display":"67,100.00","total_whole":"67,100","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4130261,"accession":"0000950170-25-008461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-008461","line_url":"/filing/0000950170-25-008461#line-1","is_derivative":false,"issuer_cik":"0001588862","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001588862","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.55,"price_display":"6.55","price_state":"stated","total_value":32750.0,"total_display":"32,750.00","total_whole":"32,750","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":2073636,"accession":"0000950170-24-134312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-134312","line_url":"/filing/0000950170-24-134312#line-1","is_derivative":false,"issuer_cik":"0001588862","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001588862","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-09","scope":"insider"},{"id":2211693,"accession":"0001062993-24-001164","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001062993-24-001164","line_url":"/filing/0001062993-24-001164","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18403.0,"shares_display":"18,403","price_per_share":23.67248787697658,"price_display":"23.67","price_state":"stated","total_value":435644.7944,"total_display":"435,644.79","total_whole":"435,645","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-22","scope":"insider","n_lines":5},{"id":8725687,"accession":"0001062993-23-022793","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-23-022793","line_url":"/filing/0001062993-23-022793","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11332.0,"shares_display":"11,332","price_per_share":21.482624955877164,"price_display":"21.48","price_state":"stated","total_value":243441.106,"total_display":"243,441.11","total_whole":"243,441","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-18","scope":"insider","n_lines":2},{"id":8318208,"accession":"0001062993-23-021139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-021139","line_url":"/filing/0001062993-23-021139#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11342.0,"shares_display":"11,342","price_per_share":18.2766,"price_display":"18.28","price_state":"stated","total_value":207293.1972,"total_display":"207,293.20","total_whole":"207,293","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-17","scope":"insider"},{"id":7802821,"accession":"0001062993-23-019549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-019549","line_url":"/filing/0001062993-23-019549#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21743.0,"shares_display":"21,743","price_per_share":14.0708,"price_display":"14.07","price_state":"stated","total_value":305941.4044,"total_display":"305,941.40","total_whole":"305,941","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-18","filed_date":"2023-10-18","scope":"insider"},{"id":8284354,"accession":"0001062993-23-018280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-018280","line_url":"/filing/0001062993-23-018280#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21746.0,"shares_display":"21,746","price_per_share":16.2206,"price_display":"16.22","price_state":"stated","total_value":352733.1676,"total_display":"352,733.17","total_whole":"352,733","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-19","scope":"insider"},{"id":8532572,"accession":"0001062993-23-016871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-016871","line_url":"/filing/0001062993-23-016871#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21746.0,"shares_display":"21,746","price_per_share":11.4669,"price_display":"11.47","price_state":"stated","total_value":249359.2074,"total_display":"249,359.21","total_whole":"249,359","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-18","scope":"insider"},{"id":8672602,"accession":"0001062993-23-015088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-015088","line_url":"/filing/0001062993-23-015088#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21749.0,"shares_display":"21,749","price_per_share":11.4267,"price_display":"11.43","price_state":"stated","total_value":248519.2983,"total_display":"248,519.30","total_whole":"248,519","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-19","scope":"insider"},{"id":8139612,"accession":"0001062993-23-013932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-013932","line_url":"/filing/0001062993-23-013932#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21749.0,"shares_display":"21,749","price_per_share":8.1559,"price_display":"8.16","price_state":"stated","total_value":177382.6691,"total_display":"177,382.67","total_whole":"177,383","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":8647653,"accession":"0001062993-23-011865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-011865","line_url":"/filing/0001062993-23-011865#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (President of R&D)","role_mark":"O","role_mark_label":"Officer (President of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21749.0,"shares_display":"21,749","price_per_share":9.0757,"price_display":"9.08","price_state":"stated","total_value":197387.3993,"total_display":"197,387.40","total_whole":"197,387","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":5353788,"accession":"0001209191-17-059523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-059523","line_url":"/filing/0001209191-17-059523","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":8.66812,"price_display":"8.67","price_state":"stated","total_value":43340.6,"total_display":"43,340.60","total_whole":"43,341","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider","n_lines":2},{"id":4162944,"accession":"0001209191-17-046041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-046041","line_url":"/filing/0001209191-17-046041","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.42746,"price_display":"7.43","price_state":"stated","total_value":37137.3,"total_display":"37,137.30","total_whole":"37,137","shares_owned_after":8100.0,"shares_owned_after_display":"8,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-24","scope":"insider","n_lines":4},{"id":2091220,"accession":"0001179110-16-023172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-023172","line_url":"/filing/0001179110-16-023172#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (Sr. Vice President)","role_mark":"O","role_mark_label":"Officer (Sr. Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. Vice President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":5040.0,"total_display":"5,040.00","total_whole":"5,040","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-19","scope":"insider"},{"id":8479011,"accession":"0001179110-15-008140","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-008140","line_url":"/filing/0001179110-15-008140","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001588862","owner_name":"McWherter Charles","owner_display_name":"McWherter Charles","owner_url":"/insider/0001588862","role":"Officer (Sr. Vice President)","role_mark":"O","role_mark_label":"Officer (Sr. Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. Vice President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.1592,"price_display":"3.16","price_state":"stated","total_value":6318.4,"total_display":"6,318.40","total_whole":"6,318","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-19","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Director","n_filings":2,"first_seen":"2024-12-09","last_seen":"2025-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001042074","name":"CymaBay Therapeutics, Inc.","url":"/issuer/0001042074","role":"Officer (President of R&D)","n_filings":13,"first_seen":"2015-05-19","last_seen":"2024-01-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001588862","retrieved_at":"2026-08-26T17:27:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}